Cure Leukaemia, has been selected as the charity partner for Deloitte in Birmingham in 2013/14.
The leading business advisory firm, which employs over 600 people at its Birmingham office, is backing Cure Leukaemia’s vision to raise £10 million over the next 10 years. Deloitte joins a roster of high profile partners including Pinsent Masons, OGL, Free Radio, Aston Villa and Warwickshire County Cricket Club.
Celebrating its 10th anniversary this year, Cure Leukaemia was founded to support the world class Centre for Clinical Haematology at The QE Hospital Birmingham, and the work of Professor Charlie Craddock and his team to fund life-saving clinical trials.
The charity funds 15 specialist research nurses based at hospitals across the West Midlands including The QE Hospital Birmingham, Sandwell and Dudley, Stoke, Worcester, Coventry and Warwickshire, and also supports Birmingham Children’s Hospital.
As part of the charity partnership, 50 colleagues from Deloitte’s Birmingham office are joining Team Cure Leukaemia in the Bupa Great Birmingham Run on Sunday 20 October, in a bid to raise a combined fundraising target of over £100,000.
The team at Deloitte have also been recognised as the largest corporate team taking part in the Business Challenge, so good luck from everyone at Cure Leukaemia!
Chief Executive of Cure Leukaemia, James McLaughlin said: “We are honoured to have been chosen by such a prestigious firm as Deloitte to be their charity partner. I am convinced that our partnership with them will play a major role in helping us reach our £1 million fundraising target for the year ahead.”
Dom Wong, Partner at Deloitte, added: “Deloitte is delighted to be supporting a brilliant and genuinely world class charity based in the heart of Birmingham. Our Birmingham staff voted for Cure Leukaemia as our charity partner, and almost 50 of them have followed this up by entering the BUPA Great Birmingham Run to fundraise for them.”
How funds raised for Cure Leukaemia help save lives